Veterinary Molecular Diagnostic Market Size, Share and Growth Outlook 2026: By Product & Service (Kits & Reagents, Instruments / Hardware, Software & Services), By Technology, By Application, By Animal Type, By End User, Companies to 2034.
The global Veterinary Molecular Diagnostic Market size is forecast to increase from $1.41 Billion in 2026 to $3.06 Billion in 2034 at a CAGR of 10.15% between 2026 and 2034.
The Veterinary Molecular Diagnostic market report provides detailed analysis and outlook of Veterinary Molecular Diagnostic segments including By Product & Service (Kits & Reagents, Instruments / Hardware, Software & Services), By Technology (Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Digital PCR (dPCR), Isothermal Amplification (LAMP), DNA / RNA Sequencing, DNA Microarrays, Mass Spectrometry), By Application (Infectious Disease Testing, Viral Infections, Bacterial Infections, Parasitic Infections, Genetics & Hereditary Disease Testing, Oncology / Cancer Diagnostics, Other Applications), By Animal Type (Companion Animals, Dogs, Cats, Horses, Livestock / Production Animals, Cattle, Poultry, Swine, Aquaculture), By End User (Veterinary Hospitals & Clinics, Reference Laboratories, Point-of-Care / In-Clinic Testing, Research Institutes & Universities) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Veterinary Molecular Diagnostic Industry Overview
Molecular Testing and Precision Diagnostics are Transforming Veterinary Disease Detection.
The global veterinary molecular diagnostic industry is advancing as veterinary healthcare providers increasingly adopt molecular technologies that enable earlier disease detection, rapid pathogen identification, and precision clinical decision-making across companion animals and livestock. Growing concerns over zoonotic diseases, rising pet healthcare expenditure, expanding livestock disease surveillance, and increasing adoption of preventive veterinary medicine are driving demand for advanced molecular diagnostics. Laboratories and veterinary clinics are investing in biomarker-based assays, automated sample preparation, real-time polymerase chain reaction technologies, and point-of-care molecular platforms that improve diagnostic accuracy while reducing turnaround times for critical clinical decisions.
Advanced Biomarker Platforms and Point-of-Care Testing are Expanding Clinical Capabilities.
Manufacturers are strengthening veterinary diagnostic portfolios through innovative molecular assays and decentralized testing technologies. IDEXX Laboratories expanded international access to its IDEXX Cancer Dx™ panel by introducing the molecular diagnostic assay in the United Kingdom for early detection of canine lymphoma. The multi-modal biomarker panel identifies lymphoma-associated molecular signatures in susceptible dog breeds up to eight months before clinical symptoms become apparent, while building on deployment across nearly 6,000 veterinary practices in North America through the company's reference laboratory network. Zoetis further enhanced in-clinic diagnostics by expanding the capabilities of its Vetscan OptiCell™ analyzer to include Cellular Hemoglobin Concentration Mean and plateletcrit measurements, enabling veterinary clinics to obtain advanced hematology parameters immediately through an automated microfluidic platform rather than relying on external laboratory processing. These developments reflect the industry's increasing emphasis on earlier diagnosis, rapid clinical decision-making, and decentralized molecular testing.
Automated Molecular Workflows are Strengthening Veterinary Disease Surveillance.
Growing demand for rapid identification of infectious diseases is accelerating investment in automated molecular laboratory infrastructure supporting both companion animal and livestock healthcare. Thermo Fisher Scientific enhanced its veterinary molecular diagnostics portfolio through validation upgrades for Applied Biosystems MagMAX nucleic acid extraction systems and companion real-time polymerase chain reaction master mixes. The solutions are optimized to isolate nucleic acids from complex veterinary specimens while supporting rapid detection of high-priority diseases including avian influenza and bovine viral diarrhea across commercial diagnostic laboratories. Continued advances in automated molecular workflows, pathogen surveillance technologies, and high-performance diagnostic reagents are strengthening veterinary preparedness for emerging infectious diseases while improving disease control across global animal health systems.
Veterinary Molecular Diagnostic Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Veterinary Molecular Diagnostic market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., bioM?rieux SA, QIAGEN N.V., Zoetis Inc., Alveo Technologies, Neogen Corporation, Heska Corporation (Antech/Mars), Randox Laboratories Ltd., VCA Animal Hospitals. The Veterinary Molecular Diagnostic market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Veterinary Molecular Diagnostic industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Veterinary Molecular Diagnostic industry include- IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., bioM?rieux SA, QIAGEN N.V., Zoetis Inc., Alveo Technologies, Neogen Corporation, Heska Corporation (Antech/Mars), Randox Laboratories Ltd., VCA Animal Hospitals. The Veterinary Molecular Diagnostic market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Veterinary Molecular Diagnostic Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Veterinary Molecular Diagnostic market remains one of the strongest-performing segments in the country.
The US Veterinary Molecular Diagnostic Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Veterinary Molecular Diagnostic market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Veterinary Molecular Diagnostic industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Veterinary Molecular Diagnostic markets
Canada's strong Veterinary Molecular Diagnostic sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Veterinary Molecular Diagnostic market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Veterinary Molecular Diagnostic Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Veterinary Molecular Diagnostic market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Veterinary Molecular Diagnostic population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Veterinary Molecular Diagnostic industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Veterinary Molecular Diagnostic market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Veterinary Molecular Diagnostic sales through 2034
France Veterinary Molecular Diagnostic companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Veterinary Molecular Diagnostic Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Veterinary Molecular Diagnostic distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Veterinary Molecular Diagnostic Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Veterinary Molecular Diagnostic market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Veterinary Molecular Diagnostic industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Veterinary Molecular Diagnostic industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Veterinary Molecular Diagnostic Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Veterinary Molecular Diagnostic market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Veterinary Molecular Diagnostic market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Veterinary Molecular Diagnostic Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Veterinary Molecular Diagnostic Market Segmentation
By Product & Service
Kits & Reagents
Instruments / Hardware
Software & Services
By Technology
Polymerase Chain Reaction (PCR)
Real-Time PCR (qPCR)
Digital PCR (dPCR)
Isothermal Amplification (LAMP)
DNA / RNA Sequencing
DNA Microarrays
Mass Spectrometry
By Application
Infectious Disease Testing
Viral Infections
Bacterial Infections
Parasitic Infections
Genetics & Hereditary Disease Testing
Oncology / Cancer Diagnostics
Other Applications
By Animal Type
Companion Animals
Dogs
Cats
Horses
Livestock / Production Animals
Cattle
Poultry
Swine
Aquaculture
By End User
Veterinary Hospitals & Clinics
Reference Laboratories
Point-of-Care / In-Clinic Testing
Research Institutes & Universities
Leading Companies in Veterinary Molecular Diagnostic Industry (2026)
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
bioM?rieux SA
QIAGEN N.V.
Zoetis Inc.
Alveo Technologies
Neogen Corporation
Heska Corporation (Antech/Mars)
Randox Laboratories Ltd.
VCA Animal Hospitals
Countries Included
The Veterinary Molecular Diagnostic market report provides detailed analysis and outlook of Veterinary Molecular Diagnostic segments including By Product & Service (Kits & Reagents, Instruments / Hardware, Software & Services), By Technology (Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Digital PCR (dPCR), Isothermal Amplification (LAMP), DNA / RNA Sequencing, DNA Microarrays, Mass Spectrometry), By Application (Infectious Disease Testing, Viral Infections, Bacterial Infections, Parasitic Infections, Genetics & Hereditary Disease Testing, Oncology / Cancer Diagnostics, Other Applications), By Animal Type (Companion Animals, Dogs, Cats, Horses, Livestock / Production Animals, Cattle, Poultry, Swine, Aquaculture), By End User (Veterinary Hospitals & Clinics, Reference Laboratories, Point-of-Care / In-Clinic Testing, Research Institutes & Universities) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Veterinary Molecular Diagnostic Industry Overview
Molecular Testing and Precision Diagnostics are Transforming Veterinary Disease Detection.
The global veterinary molecular diagnostic industry is advancing as veterinary healthcare providers increasingly adopt molecular technologies that enable earlier disease detection, rapid pathogen identification, and precision clinical decision-making across companion animals and livestock. Growing concerns over zoonotic diseases, rising pet healthcare expenditure, expanding livestock disease surveillance, and increasing adoption of preventive veterinary medicine are driving demand for advanced molecular diagnostics. Laboratories and veterinary clinics are investing in biomarker-based assays, automated sample preparation, real-time polymerase chain reaction technologies, and point-of-care molecular platforms that improve diagnostic accuracy while reducing turnaround times for critical clinical decisions.
Advanced Biomarker Platforms and Point-of-Care Testing are Expanding Clinical Capabilities.
Manufacturers are strengthening veterinary diagnostic portfolios through innovative molecular assays and decentralized testing technologies. IDEXX Laboratories expanded international access to its IDEXX Cancer Dx™ panel by introducing the molecular diagnostic assay in the United Kingdom for early detection of canine lymphoma. The multi-modal biomarker panel identifies lymphoma-associated molecular signatures in susceptible dog breeds up to eight months before clinical symptoms become apparent, while building on deployment across nearly 6,000 veterinary practices in North America through the company's reference laboratory network. Zoetis further enhanced in-clinic diagnostics by expanding the capabilities of its Vetscan OptiCell™ analyzer to include Cellular Hemoglobin Concentration Mean and plateletcrit measurements, enabling veterinary clinics to obtain advanced hematology parameters immediately through an automated microfluidic platform rather than relying on external laboratory processing. These developments reflect the industry's increasing emphasis on earlier diagnosis, rapid clinical decision-making, and decentralized molecular testing.
Automated Molecular Workflows are Strengthening Veterinary Disease Surveillance.
Growing demand for rapid identification of infectious diseases is accelerating investment in automated molecular laboratory infrastructure supporting both companion animal and livestock healthcare. Thermo Fisher Scientific enhanced its veterinary molecular diagnostics portfolio through validation upgrades for Applied Biosystems MagMAX nucleic acid extraction systems and companion real-time polymerase chain reaction master mixes. The solutions are optimized to isolate nucleic acids from complex veterinary specimens while supporting rapid detection of high-priority diseases including avian influenza and bovine viral diarrhea across commercial diagnostic laboratories. Continued advances in automated molecular workflows, pathogen surveillance technologies, and high-performance diagnostic reagents are strengthening veterinary preparedness for emerging infectious diseases while improving disease control across global animal health systems.
Veterinary Molecular Diagnostic Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Veterinary Molecular Diagnostic market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., bioM?rieux SA, QIAGEN N.V., Zoetis Inc., Alveo Technologies, Neogen Corporation, Heska Corporation (Antech/Mars), Randox Laboratories Ltd., VCA Animal Hospitals. The Veterinary Molecular Diagnostic market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Veterinary Molecular Diagnostic industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Veterinary Molecular Diagnostic Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Veterinary Molecular Diagnostic companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Veterinary Molecular Diagnostic markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Veterinary Molecular Diagnostic industry include- IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., bioM?rieux SA, QIAGEN N.V., Zoetis Inc., Alveo Technologies, Neogen Corporation, Heska Corporation (Antech/Mars), Randox Laboratories Ltd., VCA Animal Hospitals. The Veterinary Molecular Diagnostic market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Veterinary Molecular Diagnostic Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Veterinary Molecular Diagnostic market remains one of the strongest-performing segments in the country.
The US Veterinary Molecular Diagnostic Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Veterinary Molecular Diagnostic market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Veterinary Molecular Diagnostic industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Veterinary Molecular Diagnostic markets
Canada's strong Veterinary Molecular Diagnostic sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Veterinary Molecular Diagnostic market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Veterinary Molecular Diagnostic Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Veterinary Molecular Diagnostic market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Veterinary Molecular Diagnostic population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Veterinary Molecular Diagnostic industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Veterinary Molecular Diagnostic market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Veterinary Molecular Diagnostic sales through 2034
France Veterinary Molecular Diagnostic companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Veterinary Molecular Diagnostic Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Veterinary Molecular Diagnostic distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Veterinary Molecular Diagnostic Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Veterinary Molecular Diagnostic market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Veterinary Molecular Diagnostic industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Veterinary Molecular Diagnostic industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Veterinary Molecular Diagnostic Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Veterinary Molecular Diagnostic market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Veterinary Molecular Diagnostic market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Veterinary Molecular Diagnostic Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Veterinary Molecular Diagnostic Market Segmentation
By Product & Service
Kits & Reagents
Instruments / Hardware
Software & Services
By Technology
Polymerase Chain Reaction (PCR)
Real-Time PCR (qPCR)
Digital PCR (dPCR)
Isothermal Amplification (LAMP)
DNA / RNA Sequencing
DNA Microarrays
Mass Spectrometry
By Application
Infectious Disease Testing
Viral Infections
Bacterial Infections
Parasitic Infections
Genetics & Hereditary Disease Testing
Oncology / Cancer Diagnostics
Other Applications
By Animal Type
Companion Animals
Dogs
Cats
Horses
Livestock / Production Animals
Cattle
Poultry
Swine
Aquaculture
By End User
Veterinary Hospitals & Clinics
Reference Laboratories
Point-of-Care / In-Clinic Testing
Research Institutes & Universities
Leading Companies in Veterinary Molecular Diagnostic Industry (2026)
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
bioM?rieux SA
QIAGEN N.V.
Zoetis Inc.
Alveo Technologies
Neogen Corporation
Heska Corporation (Antech/Mars)
Randox Laboratories Ltd.
VCA Animal Hospitals
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Veterinary Molecular Diagnostic Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Veterinary Molecular Diagnostic Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Veterinary Molecular Diagnostic Markets in 2026
3.2. Global Historic and Forecast Veterinary Molecular Diagnostic Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Veterinary Molecular Diagnostic Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Veterinary Molecular Diagnostic Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Veterinary Molecular Diagnostic Value Chain
CHAPTER 4- VETERINARY MOLECULAR DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Veterinary Molecular Diagnostic Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product & Service
Kits & Reagents
Instruments / Hardware
Software & Services
By Technology
Polymerase Chain Reaction (PCR)
Real-Time PCR (qPCR)
Digital PCR (dPCR)
Isothermal Amplification (LAMP)
DNA / RNA Sequencing
DNA Microarrays
Mass Spectrometry
By Application
Infectious Disease Testing
Viral Infections
Bacterial Infections
Parasitic Infections
Genetics & Hereditary Disease Testing
Oncology / Cancer Diagnostics
Other Applications
By Animal Type
Companion Animals
Dogs
Cats
Horses
Livestock / Production Animals
Cattle
Poultry
Swine
Aquaculture
By End User
Veterinary Hospitals & Clinics
Reference Laboratories
Point-of-Care / In-Clinic Testing
Research Institutes & Universities
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Veterinary Molecular Diagnostic Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
7.5. North America Veterinary Molecular Diagnostic Market Size Outlook by Type
7.6. North America Veterinary Molecular Diagnostic Market Size Outlook by Application
7.7. North America Veterinary Molecular Diagnostic Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Veterinary Molecular Diagnostic Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Veterinary Molecular Diagnostic Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Veterinary Molecular Diagnostic Companies
CHAPTER 8- EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Veterinary Molecular Diagnostic Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
8.5. Europe Veterinary Molecular Diagnostic Market Size Outlook by Type
8.6. Europe Veterinary Molecular Diagnostic Market Size Outlook by Application
8.7. Europe Veterinary Molecular Diagnostic Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Veterinary Molecular Diagnostic Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Veterinary Molecular Diagnostic Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Veterinary Molecular Diagnostic Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Veterinary Molecular Diagnostic Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Veterinary Molecular Diagnostic Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Veterinary Molecular Diagnostic Companies
CHAPTER 9- ASIA PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Veterinary Molecular Diagnostic Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Veterinary Molecular Diagnostic Market Size Outlook by Type
9.6. Asia Pacific Veterinary Molecular Diagnostic Market Size Outlook by Application
9.7. Asia Pacific Veterinary Molecular Diagnostic Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Veterinary Molecular Diagnostic Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Veterinary Molecular Diagnostic Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Veterinary Molecular Diagnostic Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Veterinary Molecular Diagnostic Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Veterinary Molecular Diagnostic Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Veterinary Molecular Diagnostic Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Veterinary Molecular Diagnostic Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
10.5. South and Central America Veterinary Molecular Diagnostic Market Size Outlook by Type
10.6. South and Central America Veterinary Molecular Diagnostic Market Size Outlook by Application
10.7. South and Central America Veterinary Molecular Diagnostic Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Veterinary Molecular Diagnostic Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Veterinary Molecular Diagnostic Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Veterinary Molecular Diagnostic Companies
CHAPTER 11- MIDDLE EAST AND AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Veterinary Molecular Diagnostic Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Veterinary Molecular Diagnostic Market Size Outlook by Type
11.6. Middle East and Africa Veterinary Molecular Diagnostic Market Size Outlook by Application
11.7. Middle East and Africa Veterinary Molecular Diagnostic Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Veterinary Molecular Diagnostic Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Veterinary Molecular Diagnostic Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Veterinary Molecular Diagnostic Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Veterinary Molecular Diagnostic Industry
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
bioM?rieux SA
QIAGEN N.V.
Zoetis Inc.
Alveo Technologies
Neogen Corporation
Heska Corporation (Antech/Mars)
Randox Laboratories Ltd.
VCA Animal Hospitals
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Veterinary Molecular Diagnostic Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Veterinary Molecular Diagnostic Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Veterinary Molecular Diagnostic Markets in 2026
3.2. Global Historic and Forecast Veterinary Molecular Diagnostic Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Veterinary Molecular Diagnostic Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Veterinary Molecular Diagnostic Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Veterinary Molecular Diagnostic Value Chain
CHAPTER 4- VETERINARY MOLECULAR DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Veterinary Molecular Diagnostic Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product & Service
Kits & Reagents
Instruments / Hardware
Software & Services
By Technology
Polymerase Chain Reaction (PCR)
Real-Time PCR (qPCR)
Digital PCR (dPCR)
Isothermal Amplification (LAMP)
DNA / RNA Sequencing
DNA Microarrays
Mass Spectrometry
By Application
Infectious Disease Testing
Viral Infections
Bacterial Infections
Parasitic Infections
Genetics & Hereditary Disease Testing
Oncology / Cancer Diagnostics
Other Applications
By Animal Type
Companion Animals
Dogs
Cats
Horses
Livestock / Production Animals
Cattle
Poultry
Swine
Aquaculture
By End User
Veterinary Hospitals & Clinics
Reference Laboratories
Point-of-Care / In-Clinic Testing
Research Institutes & Universities
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Veterinary Molecular Diagnostic Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
7.5. North America Veterinary Molecular Diagnostic Market Size Outlook by Type
7.6. North America Veterinary Molecular Diagnostic Market Size Outlook by Application
7.7. North America Veterinary Molecular Diagnostic Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Veterinary Molecular Diagnostic Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Veterinary Molecular Diagnostic Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Veterinary Molecular Diagnostic Companies
CHAPTER 8- EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Veterinary Molecular Diagnostic Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
8.5. Europe Veterinary Molecular Diagnostic Market Size Outlook by Type
8.6. Europe Veterinary Molecular Diagnostic Market Size Outlook by Application
8.7. Europe Veterinary Molecular Diagnostic Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Veterinary Molecular Diagnostic Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Veterinary Molecular Diagnostic Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Veterinary Molecular Diagnostic Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Veterinary Molecular Diagnostic Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Veterinary Molecular Diagnostic Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Veterinary Molecular Diagnostic Companies
CHAPTER 9- ASIA PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Veterinary Molecular Diagnostic Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Veterinary Molecular Diagnostic Market Size Outlook by Type
9.6. Asia Pacific Veterinary Molecular Diagnostic Market Size Outlook by Application
9.7. Asia Pacific Veterinary Molecular Diagnostic Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Veterinary Molecular Diagnostic Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Veterinary Molecular Diagnostic Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Veterinary Molecular Diagnostic Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Veterinary Molecular Diagnostic Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Veterinary Molecular Diagnostic Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Veterinary Molecular Diagnostic Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Veterinary Molecular Diagnostic Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
10.5. South and Central America Veterinary Molecular Diagnostic Market Size Outlook by Type
10.6. South and Central America Veterinary Molecular Diagnostic Market Size Outlook by Application
10.7. South and Central America Veterinary Molecular Diagnostic Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Veterinary Molecular Diagnostic Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Veterinary Molecular Diagnostic Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Veterinary Molecular Diagnostic Companies
CHAPTER 11- MIDDLE EAST AND AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Veterinary Molecular Diagnostic Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Veterinary Molecular Diagnostic Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Veterinary Molecular Diagnostic Market Size Outlook by Type
11.6. Middle East and Africa Veterinary Molecular Diagnostic Market Size Outlook by Application
11.7. Middle East and Africa Veterinary Molecular Diagnostic Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Veterinary Molecular Diagnostic Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Veterinary Molecular Diagnostic Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Veterinary Molecular Diagnostic Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Veterinary Molecular Diagnostic Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Veterinary Molecular Diagnostic Industry
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
bioM?rieux SA
QIAGEN N.V.
Zoetis Inc.
Alveo Technologies
Neogen Corporation
Heska Corporation (Antech/Mars)
Randox Laboratories Ltd.
VCA Animal Hospitals
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
